Cargando…

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

BACKGROUND: Immunotherapy has revolutionized therapeutic patterns of small cell lung cancer (SCLC). Human leukocyte antigen class II (HLA class II) is related to antitumor immunity. However, the implications of HLA class II in SCLC remain incompletely understood. MATERIALS AND METHODS: We investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peixin, Zhao, Lishu, Wang, Hao, Zhang, Liping, Zhang, Wei, Zhu, Jun, Yu, Jia, Zhao, Sha, Li, Wei, Sun, Chenglong, Wu, Chunyan, He, Yayi, Zhou, Caicun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351500/ https://www.ncbi.nlm.nih.gov/pubmed/34362829 http://dx.doi.org/10.1136/jitc-2021-002554

Ejemplares similares

Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2020)

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
por: Jiang, Minlin, et al.
Publicado: (2021)

Killer immunoglobulin-like receptors/human leukocyte antigen class-I, a crucial immune pathway in cancer
por: Xu, Yi, et al.
Publicado: (2020)

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
por: Chen, Peixin, et al.
Publicado: (2021)

Regulation of tumor growth by leukocyte-specific protein 1 in T cells
por: Kwon, Riri, et al.
Publicado: (2020)

Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
por: Shi, Wei, et al.
Publicado: (2021)

Single-cell transcriptomics reveals a low CD8(+) T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma
por: Peng, Yu-Lu, et al.
Publicado: (2022)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
por: Ragone, Concetta, et al.
Publicado: (2021)

Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
por: Guo, Haoyue, et al.
Publicado: (2021)

MDSCs-derived GPR84 induces CD8(+) T-cell senescence via p53 activation to suppress the antitumor response
por: Liu, Jinyan, et al.
Publicado: (2023)

Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
por: Zhou, Wenbin, et al.
Publicado: (2021)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression
por: Xu, Jiuhui, et al.
Publicado: (2023)

Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers
por: Hu, Chunhong, et al.
Publicado: (2021)

Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells
por: Neo, Shi Yong, et al.
Publicado: (2022)

FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer
por: Liu, Jiaxin, et al.
Publicado: (2022)

Fetal exposure to oncoantigen elicited antigen-specific adaptive immunity against tumorigenesis
por: Chen, Jeng-Chang, et al.
Publicado: (2020)

Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators
por: Hou, Jiakai, et al.
Publicado: (2021)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
por: Guo, Haoyue, et al.
Publicado: (2021)

Dual receptor T cells mediate effective antitumor immune responses via increased recognition of tumor antigens
por: Jang, Hyun J, et al.
Publicado: (2023)

Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
por: Lee, Maxwell Y, et al.
Publicado: (2021)

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S
por: Harryvan, Tom J, et al.
Publicado: (2022)

Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744
por: Friedrich, Michael, et al.
Publicado: (2020)

HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment
por: Ning, Yongling, et al.
Publicado: (2020)

Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
por: Yan, Wan-Lun, et al.
Publicado: (2021)

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
por: Molvi, Zaki, et al.
Publicado: (2023)

Expression of human leukocyte antigen class I and β2‐microglobulin in colorectal cancer and its prognostic impact
por: Na, Hee Young, et al.
Publicado: (2020)

Tryptophan potentiates CD8(+) T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation
por: Qin, Rui, et al.
Publicado: (2021)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
por: McAuliffe, James, et al.
Publicado: (2021)

Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer
por: Sun, Chenglong, et al.
Publicado: (2020)

A signature for pan-cancer prognosis based on neutrophil extracellular traps
por: Zhang, Yi, et al.
Publicado: (2022)

Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells
por: Thelen, Martin, et al.
Publicado: (2022)

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy
por: Bao, Xuanwen, et al.
Publicado: (2020)

Cell death induced by cytotoxic CD8(+) T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens
por: Jaime-Sanchez, Paula, et al.
Publicado: (2020)

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2020)

Single-cell sequencing on CD8(+) TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer
por: Komuro, Hiroyasu, et al.
Publicado: (2023)

Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer
por: Marwitz, Sebastian, et al.
Publicado: (2021)

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2023)

IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
por: Wu, Qi, et al.
Publicado: (2021)

Local anesthetics elicit immune-dependent anticancer effects
por: Bezu, Lucillia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bm92nev9qg8kj4nfjm43nlgmgu